![](https://www.pymnts.com/wp-content/uploads/2020/04/shutterstock_1155290473-e1632311818693.jpg)
Swiss pharmaceutical giant Novartis has confirmed it received a binding offer from Siemens Healthineers, the German health technology company, to acquire its molecular imaging business focused on Fluorine-18 positron emission tomography (PET) scans. This diagnostic arm is part of Advanced Accelerator Applications, a subsidiary Novartis acquired in 2017.
According to Reuters, the offer from Siemens Healthineers is valued at over 200 million euros ($224 million). The acquisition will enable Siemens to expand its capabilities in the field of diagnostic imaging, particularly in PET scans, which are crucial in diagnosing and monitoring cancer.
While Novartis did not disclose the exact value of the deal in a statement to Reuters, the company emphasized that Siemens Healthineers would continue to collaborate with Novartis in its radioligand therapy (RLT) business. The pharmaceutical firm expects the transaction to be finalized by the fourth quarter of this year.
Neither Advanced Accelerator Applications nor Siemens Healthineers provided immediate comments on the deal outside regular business hours, as reported by Reuters.
Novartis initially acquired Advanced Accelerator Applications for $3.9 billion, aiming to enhance its portfolio of cancer treatments that utilize radioactive substances. Fluorine-18, as described by the U.S. National Cancer Institute, is a radioactive agent used in PET imaging to diagnose cancer and assess the effectiveness of treatments. This acquisition marks a significant step for Siemens Healthineers in advancing its diagnostic imaging capabilities.
Source: Reuters
Featured News
UK Professor Files Multi-Million Pound Suit Against Google’s Play Store
Aug 25, 2024 by
CPI
Australia’s Competition Watchdog to Monitor Airfares After Airline Withdrawals
Aug 25, 2024 by
CPI
Tech Leaders Warn Europe Risks Falling Behind Due to Complex AI Regulations
Aug 25, 2024 by
CPI
Siemens Healthineers Bids Over €200 Million for Novartis’ PET Imaging Business
Aug 25, 2024 by
CPI
Restaurants Resist Regulatory Crackdown on ‘Junk Fees
Aug 25, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – State Attorneys General
Aug 22, 2024 by
CPI
CPI Talks… …With Attorney General Phil Weiser
Aug 22, 2024 by
CPI
The Bipartisan Miracle of State Antitrust Enforcement
Aug 22, 2024 by
Gwendolyn J. Lindsay Cooley
Recent Developments in State Antitrust Enforcement: Agriculture and Food Markets
Aug 22, 2024 by
Elizabeth R. Odette
State Attorneys General: Stewards of Consumer Health and Welfare
Aug 22, 2024 by
Brooke Howlett Lovrovich